Four-Repeat Tauopathy Neuroimaging Initiative | Clinical Research Studies Listing

Recruiting

99 years or below

All

Brief description of study

New treatments that target the protein tau are beginning to enter human clinical trials. While tau-related therapies hold great promise for AD, clinical trials focusing on pure tauopathies are appealing because these diseases do not exhibit concurrent amyloid pathology. Pure 4 microtubule binding repeat (4R) tauopathies (4RT) include corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and some variants of frontotemporal lobar degeneration. There are no approved or effective therapies for 4RT. We designed 4RTNI to develop biomarkers of disease progression in CBD and PSP; such biomarkers may facilitate clinical trials for 4RT tauopathies.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: ['Corticobasal Degeneration (CBD)', 'Corticobasal Syndrome (CBS)', 'Cortical-basal Ganglionic Degeneration (CBGD)', 'Progressive Supranuclear Palsy (PSP)', 'Nonfluent Variant Primary Progressive Aphasia (nfvPPA)', 'Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)']
Age: 99 years or below
Gender: All

Updated on 19 Feb 2024. Study ID: 826254

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.